↓ Skip to main content

Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better for patients, better for healthcare systems

Overview of attention for article published in Frontiers in oncology, August 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

twitter
9 X users
facebook
1 Facebook page
wikipedia
2 Wikipedia pages
video
1 YouTube creator

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Global adoption of single-shot targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer—better for patients, better for healthcare systems
Published in
Frontiers in oncology, August 2022
DOI 10.3389/fonc.2022.786515
Pubmed ID
Authors

Jayant Sharad Vaidya, Uma Jayant Vaidya, Michael Baum, Max Kishor Bulsara, David Joseph, Jeffrey S. Tobias

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Other 4 22%
Student > Ph. D. Student 2 11%
Student > Bachelor 1 6%
Professor 1 6%
Researcher 1 6%
Other 0 0%
Unknown 9 50%
Readers by discipline Count As %
Medicine and Dentistry 4 22%
Biochemistry, Genetics and Molecular Biology 1 6%
Materials Science 1 6%
Nursing and Health Professions 1 6%
Unknown 11 61%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 December 2022.
All research outputs
#4,310,147
of 26,169,168 outputs
Outputs from Frontiers in oncology
#1,437
of 22,913 outputs
Outputs of similar age
#82,359
of 436,852 outputs
Outputs of similar age from Frontiers in oncology
#89
of 1,809 outputs
Altmetric has tracked 26,169,168 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,913 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 436,852 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 1,809 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.